Our People

Our scientific team is comprised of biologists, virologists and medicinal chemists with extensive drug discovery and development experience. Our efforts are further supported by a host of highly experienced collaborators and through funding from the National Institute for Allergy and Infectious Disease.

Management Team

Ken McCormack, Ph.D. - President

Dr. McCormack, who previously held scientific and management positions at Narogen, Icagen and Vertex Pharmaceuticals, manages the corporate activities and R&D operations.

Greg Henkel, Ph.D. - Vice President

Dr. Henkel oversees R&D operations directing biology and drug development efforts. Dr. Henkel previously led drug development programs as Director of Biology at Vertex Pharmaceuticals.

Michael Plewe, Ph.D. - Head of Chemistry

Dr. Plewe manages chemistry drug development efforts. Dr. Plewe previously directed antiviral chemistry programs at Pfizer as Associate Research Fellow.

Catherine Howard - Financials

Ms. Howard manages accounting and financial operations.

Doug Murphy - Information Technology

Mr. Murphy is responsible for database and IT systems management.

X

Creative Commons Attribution: